Transactions
Showing 1995-2009 of 4170 items
-
C$23m
Delta 9 Cannabis
Lead (Bought Deal)
-
C$58m
OrganiGram
Co-Manager (Equity Financing)
-
C$11m
Khiron Life Sciences Corp
Lead (RTO Financing)
-
C$17m
Hiku Brands Company
Sole Bookrunner (Equity Follow-on)
-
C$32m
LOGiQ
Financial Advisor to LOGiQ on its sale to Purpose Investments
-
C$18m
Doja
Lead (Convert. Debenture)
-
US$300m
Blueprint Medicines
Co-Manager (Follow-on)
-
C$16m
Sante Veritas Therapeutics
Co-Lead (Private Placement)
-
A$23m
Northern Star
Broker & Advisor (Strategic Investment)
-
US$60m
Helios and Matheson Analytics Inc.
Sole Bookrunner (Equity Offering)
-
C$5m
LexaGene Holdings
Sole Bookrunner (Equity Follow-on)
-
N/a
Health Connect America
Financial Advisor on sale to Harren Equity Partners
-
C$26m
Mogo Finance Technology Inc.
Co-Lead (Bought Deal)
-
A$7m
Building IQ Ltd
Lead Manager (Placement)
-
N/a
Galena Biopharma
Financial Advisor to Galena Biopharma on its merger with SELLAS Life Sciences Group, Inc.